Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00164281
Status:
COMPLETED
Last Update Posted:
2014-02-06
First Post:
2005-09-09
Brief Title:
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
Sponsor:
Centers for Disease Control and Prevention
Organization:
Centers for Disease Control and Prevention
Study Overview
Official Title:
A Randomized Placebo-Controlled Study of Limited vs Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized blinded two-arm comparative trial of continued versus limited isoniazid INH tuberculosis TB preventive therapy in HIV-infected adults in Gaborone and Francistown Botswana Subjects will be accrued over two years and followed for a minimum of 36 months
Detailed Description:
Randomized double blinded two-arm comparative trial of continuous vs limited isoniazid preventive therapy in HIV-infected adults in Gaborone and Francistown Botswana Subjects will be accrued over two years and followed for a minimum of 36 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None